Last reviewed · How we verify
NCT05838222
Integrating Solution Focused Interventions in Integrated Care
NA trial testing Solution Focused Intervention in Depression in 80 participants. Completed in 2 October 2023.
11 August 2023
Quick facts
| Lead sponsor | University of Georgia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 8 May 2023 |
| Primary completion | 11 August 2023 |
| Estimated completion | 2 October 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Solution Focused Intervention
- Treatment as Usual
Conditions studied
- Depression — all drugs for Depression →
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
- Hypertension — all drugs for Hypertension →
- Anxiety Disorders — all drugs for Anxiety Disorders →
Sponsor
University of Georgia
Who can join
18 and older, any sex, with Depression or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Integrated behavioral healthcare (IBH) emerged to address the high prevalence of psychosocial issues endemic to primary care settings coupled with primary care provider's discomfort in addressing psychosocial issues. IBH addresses the lack of psychosocial care in primary care settings by expanding the traditional healthcare team through the inclusion of a behavioral health provider (clinical social worker, licensed psychologist, etc.). The behavioral health provider utilizes evidenced based interventions to support the healthcare team with addressing a wide range of healthcare concerns. Solution Focused Brief Therapy (SFBT) provides a promising treatment approach within IBH settings due to the high productivity standards within primary care and the efficient, solution based style foundational to SFBT. In addition, SFBT is strengths based and emphasizes patient centered approaches which primary care aspires to achieve. Despite the natural fit, there is a paucity of research regarding SFBT within integrated care settings in general, and for specific disease states. The purpose of this study is to assess the efficacy of SFBT within an IBH setting in the treatment of depression while assessing for commensurate improvement with traditional healthcare markers such as A1C, blood pressure, pulse, and weight. In addition, scaling questions will be utilized to assess for increase in core SFBT constructs to include self-awareness of strengths, future hope, and increased ability to problem solve. A pre-posttest experimental design will assess the differences between those receiving SFBT and treatment as usual across symptoms of depression, SFBT core attributes, and health outcomes.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Addressing depression and comorbid health conditions through solution-focused brief therapy in an integrated care setting: a randomized clinical trial.
Cooper ZW, Mowbray O, Ali MK, Johnson LCM. · · 2024 · cited 4× · PMID 39179982 · DOI 10.1186/s12875-024-02561-8 -
Strategies for Fidelity Monitoring a Solution-Focused Brief Intervention in a Randomized Clinical Trial.
Cooper ZW, Johnson L. · · 2025 · cited 1× · PMID 39873935 · DOI 10.1007/s10880-025-10063-7 -
Strategies for Fidelity Monitoring a Solution-Focused Brief Intervention in a Randomized Clinical Trial
Cooper Z, Johnson L. · · 2024 · DOI 10.21203/rs.3.rs-4085224/v1 -
Addressing Depression and Comorbid Health Conditions through Solution-Focused Brief Therapy in an Integrated Care Setting: A Randomized Clinical Trial
Cooper Z, Mowbray O, Ali M, Johnson L. · · 2024 · DOI 10.21203/rs.3.rs-3996940/v1
Verify or expand the search:
- PubMed search for NCT05838222
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other University of Georgia trials
Trials by the same sponsor.
- NCT07173816 — Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Prevention and S · NA · not yet recruiting
- NCT06799702 — Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inje · NA · not yet recruiting
- NCT06987526 — Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alco · NA · recruiting
- NCT06193343 — Steps Towards Osteoarthritis Prevention · NA · recruiting
- NCT06424756 — Effects of an Antioxidant Supplement on Blood Vessel Health · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05838222 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Georgia
- Last refreshed: 18 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05838222.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing